INVESTORS

Successful medtech investment depends on early teams maintaining momentum through design, development, and submission and avoiding costly missteps. For many portfolio companies, the challenge isn’t just identifying what needs to be done, it’s having the capability and bandwidth to execute at the required level without prematurely hiring a full internal team.

SechMed can partner with investors and VC firms to support and strengthen their medtech portfolios. We provide experienced, execution-focused development support across design, engineering, regulatory strategy, and documentation, ensuring early companies stay on track and use capital efficiently.

Our multidisciplinary team has decades of hands-on experience taking devices from concept through CE/FDA clearance. We integrate seamlessly with portfolio companies to deliver structured development under ISO 13485 and EU/FDA frameworks.

Whether supporting a single company through a critical phase or serving as an on-demand R&D and regulatory function, SechMed helps investors de-risk projects, protect capital, and accelerate value creation across their medtech interests.

In short:
We help investors keep portfolio companies on track, with execution, structure, and clearance-focused development that protects capital and accelerates return.